Additionally, high serum concentrations of AZGP1 were detected in colon cancer patients, and the combination of AZGP1 with traditional serum biomarkers, CEA and CA19-9, resulted in a more accurate diagnostic result than the individual ones. The gene discussed is CEACAM5; the disease is colonic neoplasm.